Showing results (141-150 of 437) with videos related to
Sort By:
Pageof 44
Journal of Occupational and Environmental Medicine|May 24, 2014
Workplace health promotion: what public-sector employees want, need, and are ready to changeMichelle Kilpatrick, Kristy Sanderson, Leigh Blizzard, et al.Viral Immunology|June 30, 2012
PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infectionSonia Norris, Adam Coleman, Leticia Kuri-Cervantes, et al.Maturitas|February 18, 2026
Gender differences in quality of life and contributions of biopsychosocial factorsIssada Trakarnwijitr, Zhen Zhou, Rory Wolfe, et al.Journal of Pharmaceutical Analysis|March 4, 2020
Thermodynamics of clay-drug complex dispersions: Isothermal titration calorimetry and high-performance liquid chromatographyAna-Maria Totea, Juan Sabin, Irina Dorin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2009
Pharmacokinetics and safety of etravirine administered once or twice daily after 2 weeks treatment with efavirenz in healthy volunteersMarta Boffito, Akil Jackson, Mohammed Lamorde, et al.AIDS (London, England)|November 21, 2002
The immunological effects of concomitant highly active antiretroviral therapy and liposomal anthracycline treatment of HIV-1-associated Kaposi's sarcomaBen Esdaile, Matt Davis, Simon Portsmouth, et al.AIDS (London, England)|January 31, 2003
HIV-related lung cancer in the era of highly active antiretroviral therapyMark Bower, Tom Powles, Mark Nelson, et al.AIDS (London, England)|July 12, 2013
Can we stop CD4+ testing in patients with HIV-1 RNA suppression on antiretroviral treatment?Pierre-Marie Girard, Mark Nelson, Perry Mohammed, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2009
The nucleoside backbone affects durability of efavirenz- or nevirapine-based highly active antiretroviral therapy in antiretroviral-naive individualsNaa Torshie Annan, Mark Nelson, Sundhiya Mandalia, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004
Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control studyRachael Jones, Justin Stebbing, Mark Nelson, et al.Pageof 44